许万福，男，出生于1987年3月，研究主管，副研究员，硕士研究生导师，广州市高层次青年后备人才。发表SCI文章32篇，其中一作/共6篇，并列通讯8篇，5分上共计6篇SCI，共主持国家、省市级课题5项，主要从事儿童消化系统疾病及病毒性肠炎，指导临床医生申报并立项课题8项，已协助指导3学术型研究生和3名临床在职博士毕业。
【主要研究方向】
1. 能量代谢与胃肠道疾病发病机制; 2.临床基因突变患者的致病机制及治疗研究。
【代表性论文】
1. Inhibition of CREB-mediated ZO-1 and activation of NF-κB-induced IL-6 by colonic epithelial MCT4 destroys intestinal barrier function. Cell Prolif. 2019 Nov;52(6):e12673. doi: 10.1111/cpr.12673. Epub 2019 Aug 16.
2. Protein kinase Ds promote tumor angiogenesis through mast cell recruitment and expression of angiogenic factors in prostate cancer microenvironment. J Exp Clin Cancer Res. 2019 Mar 6;38(1):114. doi: 10.1186/s13046-019-1118-y.
3. Crosstalk of protein kinase C ε with Smad2/3 promotes tumor cell proliferation in prostate cancer cells by enhancing aerobic glycolysis.Cell Mol Life Sci. 2018 Dec;75(24):4583-4598. doi: 10.1007/s00018-018-2914-9. Epub 2018 Sep 12.
4. A far-red-emissive AIE active fluorescent probe with large stokes shift for detection of inflammatory bowel disease in vivo. J Mater Chem B. 2018 Feb 7;6(5):809-815. doi: 10.1039/c7tb03168h. Epub 2018 Jan 19.
5. MiR-1 suppresses tumor cell proliferation in colorectal cancer by inhibition of Smad3-mediated tumor glycolysis. Cell Death Dis. 2017 May 4;8(5):e2761. doi: 10.1038/cddis.2017.60.
6. Omeprazole, an inhibitor of proton pump, suppresses De novo lipogenesis in gastric epithelial cells. Biomed Pharmacother. 2020 Oct;130:110472. doi: 10.1016/j.biopha.2020.110472.
7. Rabeprazole Suppresses Cell Proliferation in Gastric Epithelial Cells by Targeting STAT3-mediated Glycolysis. March 2021, Biochemical Pharmacology DOI: 10.1016/j.bcp.2021.114525.